Literature DB >> 22378821

Urinary proteins as novel early diagnostic tools in preeclampsia?

Jane F Reckelhoff.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22378821      PMCID： PMC3362064          DOI： 10.1152/ajprenal.00090.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  10 in total

1.  Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.

Authors:  Yuping Wang; Shuang Zhao; Susan Loyd; Lynn J Groome
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

2.  An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.

Authors:  Chan-Wook Park; Joong Shin Park; Soon-Sup Shim; Jong Kwan Jun; Bo Hyun Yoon; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 3.  Pathophysiology of the clinical manifestations of preeclampsia.

Authors:  Michelle Hladunewich; S Ananth Karumanchi; Richard Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 8.237

4.  Urinary podocyte excretion as a marker for preeclampsia.

Authors:  Vesna D Garovic; Steven J Wagner; Stephen T Turner; David W Rosenthal; William J Watson; Brian C Brost; Carl H Rose; Larisa Gavrilova; Paula Craigo; Kent R Bailey; Johannes Achenbach; Mario Schiffer; Joseph P Grande
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

5.  Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.

Authors:  Donghai Yu; Arndt Petermann; Uta Kunter; Song Rong; Stuart J Shankland; Juergen Floege
Journal:  J Am Soc Nephrol       Date:  2005-04-13       Impact factor: 10.121

6.  The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development.

Authors:  P J Meis; R L Goldenberg; B M Mercer; J D Iams; A H Moawad; M Miodovnik; M K Menard; S N Caritis; G R Thurnau; S F Bottoms; A Das; J M Roberts; D McNellis
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Acute and transient podocyte loss and proteinuria in preeclampsia.

Authors:  Kumi Aita; Mio Etoh; Hiromi Hamada; Chie Yokoyama; Ayuko Takahashi; Taisei Suzuki; Masanori Hara; Michio Nagata
Journal:  Nephron Clin Pract       Date:  2009-04-18

9.  Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia.

Authors:  Shuang Zhao; Xin Gu; Lynn J Groome; Yuping Wang
Journal:  Reprod Sci       Date:  2009-06-15       Impact factor: 3.060

Review 10.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.